- Home
- DOCN vs CRNX Comparison
DOCN vs CRNX Comparison
Compare DOCN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCN | CRNX |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.1B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | DOCN | CRNX |
|---|---|---|
| Price | $53.22 | $53.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $47.77 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 1.5M | 1.5M |
| Earning Date | 02-24-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 201.90 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | ★ $863,962,000.00 | $1,535,000.00 |
| Revenue This Year | $17.17 | $425.41 |
| Revenue Next Year | $18.85 | $943.30 |
| P/E Ratio | $20.47 | ★ N/A |
| Revenue Growth | 14.20 | ★ 47.74 |
| 52 Week Low | $25.45 | $24.10 |
| 52 Week High | $54.41 | $57.99 |
Technical Indicators
Market Signals| Indicator | DOCN | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 68.52 | 65.11 |
| Support Level | $47.20 | $43.40 |
| Resistance Level | $54.41 | $57.99 |
| Average True Range (ATR) | 1.95 | 2.82 |
| MACD | 0.45 | 0.07 |
| Stochastic Oscillator | 92.64 | 68.49 |
Price Performance
Historical ComparisonAbout DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.